Trial
NCT05937152
A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Diabetic Polyneuropathy
Intervention
Eptinezumab
Why stopped
no participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-06